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Abstract 
Mechanical factors are important in the regulation of muscle phenotype. Adaptation 
of structural and mechanical proteins to withstand increased load and cope with 
increased work is needed in a muscle exposed to mechanical stimuli such as stretch. 
Small muscle protein X-chromosome (SMPX) is a protein upregulated in stretched 
skeletal muscle, and could therefore work as a structural protein, a signalling factor in 
a mechanotransduction pathway, or a combination of both. 
In my project I have studied the in vivo and ex vivo localization of SMPX in skeletal 
muscle, as well as the effects of overexpressing SMPX in the fast-twitch muscle 
extensor digitorum longus (EDL) and the slow-twitch muscle soleus in adult mice. 
In vivo and ex vivo visualization of a SMPX-EGFP fusion protein suggests that the 
majority of SMPX is localized to the sarcomeric H-zone, with a minor portion 
possibly localized as a thin band to the middle of the Z-disc in adult skeletal muscle. 
Overexpression of SMPX for 14 days gave no significant changes in fibre type 
distribution or cross sectional area in EDL. In soleus the results were variable, but 
there was a shift towards a faster fibre type and a less pronounced increase in cross 
sectional area. 
Our experiments do not support the idea that SMPX works as a major regulatory 
protein or a signalling molecule related to force transduction in the I-band. If it serves 
as a regulatory protein, our results show that this could be true for soleus, but not for 
EDL.
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1. Introduction 
Skeletal muscle is one of the most adaptive of all tissue types, and can change its 
phenotype and adapt to a variety of different conditions without cell death and 
regeneration. Adult skeletal muscles can modulate the expression of muscle specific 
genes and proteins in response to mechanical stimuli, hormones and the activity 
pattern they are exposed to. In response to these external stimuli, both individual 
muscles and muscle fibres are adapted to highly variable demands to strength, 
contraction speed and endurance. The pathway between external stimuli and gene 
expression is important in understanding these differences, and mechanical factors 
and their possible role in signalling is not well understood. 
1.1 Mechanotransduction 
The sarcomere is the specialized contractile unit of a skeletal muscle. In addition to 
its force generating structure; essential mechanical, structural and signalling proteins 
are also associated with regions of the sarcomere that do not directly participate in the 
actin-myosin interaction. The sarcomeric Z-disc, I-band, A-band, H-zone and M-line 
(see fig. 1.1) are all areas where proteins with one or more of these functions interact 
(e.g. review; Hoshijima, 2006; Kruger & Linke, 2009). 
The giant elastic titin molecule with its spring-like structure running all the way from 
the Z-disc to the M-line, develops passive force in a nonlinear and highly isoform-
dependent manner when stretched by external force (e.g. review Fukuda et al., 2008). 
It is now increasingly recognized as a key area for protein-protein interactions and 
also a putative mediator of mechanosensory processes. Titin has so far been 
demonstrated to be an interacting partner for about 20 proteins, linking titin to 
multiple stress signalling pathways (Kruger and Linke 2009). Three titin regions are 
particularly engaged in the protein-protein interactions, the NH2-terminal segment at 
the Z-disc, the elastic I-band part, and the COOH-terminal segment within and 
adjacent to the M-band (Kruger and Linke 2009). 
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Figure 1.1 Schematic drawing of a skeletal muscle sarcomere 
Only a small selection of the sarcomeric proteins is shown. Z-disc and actin filaments are 
shown in red, myosin filaments in turquoise and M-line in blue. Titin (yellow) is spanning 
from the Z-disc to the M-line, where it overlaps with titin from the opposite Z-disc. 
In a structure like skeletal muscle, a force transmitting system from the contractile 
apparatus to the bone is needed. In addition to the myotendinous junction, exerting 
longitudinal force transmission, a transversal force transmission system has been 
implicated. Costameres are described as subsarcolemmal sites of cytoskeletal-
membrane adhesion complexes, which connect the contractile apparatus with the cell 
membrane. They span over the Z-disc, M-line, and in some muscles parallel to the 
longitudinal axis of the muscle (L-line) (Pardo et al., 1983; Bloch & Gonzalez-
Serratos, 2003). Costameres are thought to reinforce the membrane and function as 
the link between the contractile elements and the extracellular matrix (ECM) (for all 
future abbreviations, see appendix B), exerting lateral force transmission (Bloch & 
Gonzalez-Serratos, 2003). The number of cytoplasmic costameric proteins is large 
and still growing (Bloch et al., 2002). Recent studies suggest that this elaborate 
protein network acts as a structural and signalling center for striated muscle, and that 
it also contains factors that can function as mechanosensors (Bloch et al., 2002; 
Hoshijima, 2006). 
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1.1.1 Muscle gene regulatory proteins 
A number of gene regulatory proteins are important for the differentiation and 
function of a skeletal muscle. A brief introduction to the ones that have been 
discussed in connection with SMPX follows. 
The four myogenic regulatory factors (MRFs) MyoD, myogenin, Myf-5 and MRF4 
form a subclass of a large group of transcription factors characterized by a common 
basic helix-loop-helix (bHLH) domain. They are exclusively expressed in skeletal 
muscle, and their immediate precursors are found to be important for expression of 
muscle specific genes during development (Krempler & Brenig, 1999). The MRFs all 
share a common DNA binding domain, which is central for its binding specificity to 
E-box DNA sequences. The MRFs function as heterodimers with a second bHLH 
protein from the E protein family, such as E47 (Murre et al., 1989). The MRFs are 
expressed at different levels and times during development, with Myf-5 and MyoD 
highly expressed in the transformation phase from somite cells to myoblasts, and 
myogenin and MRF4 expression peaking during transformation of myoblasts into 
myotubes (Buckingham, 1994). 
The expression of MRFs continues in the adult animal. MRF4 is present at relatively 
high levels compared to the other three transcription factors, with no distinct 
distribution pattern when comparing fast and slow muscles (Rhodes & Konieczny, 
1989; Voytik et al., 1993). Myf-5 is expressed at relatively low levels in adult skeletal 
muscles. MyoD and myogenin are differentially expressed; with highest levels of 
MyoD in fast muscle, and of myogenin in slow muscle, respectively (Hughes et al., 
1993; Voytik et al., 1993). MyoD can induce fast MyHC (Ekmark et al., 2007), while 
myogenin can induce higher oxidative capacity in adult skeletal muscle (Ekmark et 
al., 2003). 
Myocyte enhancer factor-2 (MEF2) proteins are another family of transcription 
factors that play a critical role in embryonic development (Potthoff & Olson, 2007). 
In adult skeletal muscle they can be a regulator of the stress-response during cardiac 
hypertrophy (Zhang et al., 2002), and function in tissue remodelling in cardiac and 
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skeletal muscle, including formation of slow-twitch myofibres in skeletal muscle 
(Potthoff et al., 2007). 
The Nuclear factor of activated T cells (NFAT) proteins are a family of transcription 
factors that are activated by slow stimulation and deactivated by muscle inactivation. 
A constitutively active form of NFAT can induce slow MyHC and inhibit MyHC type 
2b expression in adult fast muscles (Chin et al., 1998; McCullagh et al., 2004). 
1.2 Smpx background 
In a reciprocal probing screen in the search for unknown genes, Patzak et al. (1999) 
were the first to identify and characterize the small muscle protein X-chromosome 
(Smpx) gene, which is localized near the telomere on the X-chromosome. It is 
predominantly expressed in skeletal and heart muscle, and has been studied by 
several groups to try and deduce its in vivo function (Patzak et al., 1999; Kemp et al., 
2001; Christoffels et al., 2004; Schindeler et al., 2005; Ren et al., 2006; Larsen, 
2007). 
1.2.1 Structure 
SMPX consists of 85 amino acids in mouse and 86 amino acids in human and pig, 
with no paralogs. (Patzak et al., 1999; Kemp et al., 2001; Palmer et al., 2001). Both 
the gene- and protein sequence is highly conserved between the orthologs in 
vertebrates tested (frog, mouse, rat, pig and human) (Patzak et al., 1999; Kemp et al., 
2001; Palmer et al., 2001; Ren et al., 2006).  
Based on in silico methods, Patzak et al. (1999) suggested that SMPX is strongly 
coiled, with a 23 amino acid (aa) N-terminal hydrophobic domain. This could 
possibly act as a membrane-anchoring domain. The N-terminal part of SMPX shows 
the highest conservation between species, and this points to an important function of 
this part of SMPX. Furthermore, sequence comparison between human and mouse 5’ 
upstream gene sequences of Smpx showed 87% identity; even higher than that seen in 
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the mouse and human coding sequence comparison (Kemp et al., 2001).  This 
suggests functional conservation within the regulatory region. 
1.2.2 Tissue distribution and expression level 
In addition to its primary expression in heart and skeletal muscle, SMPX has also 
been found at lower levels in liver, testis, kidney, lung, large intestine and brain in 
mice (Patzak et al., 1999; Kemp et al., 2001; Palmer et al., 2001), and in stomach and 
backfat in pigs (Ren et al., 2006). 
Interestingly, in skeletal muscle, SMPX expression levels were highest in slow type I 
fibres, intermediate in fast type IIa and lowest in fast type IIb fibres (Palmer et al., 
2001). 
Analyses of SMPX distribution also demonstrated that it has a higher expression level 
in developing heart and skeletal muscle of neonatal and postnatal mice when 
compared with corresponding adult tissue. (Palmer et al., 2001). Later studies of the 
developing heart first detected SMPX in 8.25 day old mouse embryos located at the 
ventral surface of the heart progenitor region undergoing active fusion; and later in 
the outer curvature of the ventricles and in the atrial appendages (Palmer et al., 2001; 
Christoffels et al., 2004).  
A SMPX knockout mouse was made to assess the function of SMPX in muscle 
development, but no obvious developmental or structural deficits in heart or skeletal 
muscle were discovered (Palmer et al., 2001). 
1.2.3 Predicted SMPX motifs and their possible functions 
In the predicted 9.25kDa mouse and human SMPX a putative pat 7 nuclear 
localization motif, two overlapping casein kinase II (CKII) phosphorylation sites and 
a PEST sequence were found (Kemp et al., 2001). A PEST sequence indicates 
instability (Rogers et al., 1986), and when compared with other proteins known to 
undergo rapid degradation such as the transcription factors c-fos and c-myc; the 
SMPX PEST sequence was predicted to be even more unstable (Kemp et al., 2001). 
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In the predicted 9.3kDa pig SMPX, the CKII sites and PEST sequence were also 
conserved (Ren et al., 2006).  
CKII is a protein kinase, and its expression has been detected both in the nucleus and 
in the cytoplasm of cells (Stigare et al., 1993). CKII has been implicated in the 
regulation of the MRFs MyoD and MRF4, independent of their own CKII 
phosphorylation sites (Johnson et al., 1996). This suggested that CKII may act 
indirectly on MRFs via regulation by other proteins. Kemp et al. (2001) proposed 
SMPX as a candidate for this intermediate regulation of MRFs. Kemp et al. (2001) 
also suggested that phosphorylation of SMPX may regulate its function and cellular 
localization. CKII activity also increased as myoblasts differentiated and fused to 
form myotubes (Johnson et al., 1996). 
1.2.4 What can regulate SMPX in skeletal muscle? 
Putative binding sites for several muscle-specific transcription factors were found in 
the promoter region located immediately 5’ to the Smpx gene; including MyoD, 
MEF2 and Nkx2-5 (Patzak et al., 1999; Kemp et al., 2001; Palmer et al., 2001). This 
is in agreement with the high expression level of SMPX in muscle, and suggests that 
these transcription factors can be regulators of SMPX. 
Nkx2-5 is the human homologue of the Drosophila gene tinman, which has been 
identified as a candidate for the determination of the cardiac cell lineage in Zebrafish 
(Chen & Fishman, 1996). Palmer et al. (2001) found SMPX downregulated by more 
than 20 times in the heart of an Nkx2-5 null-mutant. Nkx2-5 expression has also been 
shown to increase during adrenergic (Saadane et al., 1999) and pressure induced 
(Thompson et al., 1998) cardiac hypertrophy. These results suggest a connection 
between Nkx2-5, SMPX and cardiac muscle development and hypertrophy. 
In 2003, Christoffels et al. discovered that the temporal and spatial pattern of the T-
box transcription factor Tbx2 repressed differentiation and formation of the cardiac 
chambers in mice; and expression patterns of Tbx2 and SMPX were mutually 
exclusive at all stages in myocardium development. Constitutively expressed Tbx2 in 
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the heart chambers suppressed SMPX and other chamber specific gene expression, 
and the hearts were smaller, unlooped and had the appearance of large linear heart 
tubes. Their results make SMPX a candidate for regulation of chamber 
differentiation, growth and looping (Christoffels et al., 2004). 
Passive stretch induces muscle fibre hypertrophy (Moss & Leblond, 1971; Tabary et 
al., 1972). Kemp et al. (2001) found SMPX upregulated in the tibialis anterior 
muscle in response to 7 days of passive stretch. Kemp et al. (2001) therefore 
suggested that SMPX may induce hypertrophy in adult skeletal muscle as a response 
to stretch. The process by which mechanical stimulation is detected by cells, and the 
translation of these stimuli into biological signals leading to hypertrophy is poorly 
understood. Only a few key regulators that can lead to hypertrophy have been 
identified. Insulin-like growth factor-1 (IGF-1), mechanogrowth factor (MGF) (Yang 
et al., 1996; Yang et al., 1997; Barton-Davis et al., 1998) and Prostaglandin F2α 
(Vandenburgh et al., 1995) have been proven to induce skeletal muscle hypertrophy 
in the absence of other stimuli. 
1.2.5 Intracellular localization of SMPX in skeletal muscle in mice 
In early fetal skeletal and heart muscle SMPX was evenly distributed in the cells. In 
late fetal and adult skeletal muscle SMPX was immunolocalized to repetitive double 
stripes at the level of the I-band, flanking the Z-disc (Palmer et al., 2001). Palmer et 
al. (2001) suggested the localization of SMPX to be at costameres (Berthier & 
Blaineau, 1997), supported with the finding that it co-localized with talin both in 
costameres and in myotendinous junctions. Talin is a large protein with actin-, 
vinculin-, integrin- and dystrophin-binding activities enriched in costameres. 
Costameres have a substructure consisting of densely clustered patches of vinculin, 
which are segregated into two rows which flank the Z line and span the I band of the 
underlying sarcomere (Pardo et al., 1983). 
Palmer et al. (2001) further compared the localization of SMPX with desmin, and 
pointed out the striking resemblance in the localization of these two surrounding the 
Z-disc. Desmin is an intermediate filament protein precisely surrounding the Z-disc of 
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myofibrils in a cage-like manner in continuity with costameres at the membrane 
(Granger & Lazarides, 1979). Linking adjacent Z-discs together, desmin is a part of 
the force transmission system (Shah et al., 2002). 
In skeletal muscle, a weak single stripe of SMPX was also seen at the level of the M-
line (Palmer et al., 2001). In fibre cross sections of fetal myotubes Palmer et al. 
(2001) also found that SMPX was located predominantly surrounding or in between 
myofibrils, unlike α-actinin, which was located throughout the myofibril at the level 
of the Z-disc. The same localization pattern of SMPX was also seen in cardiac 
muscles; however here the M-line signal was more prominent than in skeletal muscles 
(Palmer et al., 2001). The M-line signal was not further discussed in Palmer et al. 
(2001). 
1.2.6 Intracellular localization of SMPX in cell culture 
Kemp et al. (2001) immunolocalized SMPX at varying levels to the nuclei of 
mononucleate C2C12 myoblasts, while SMPX was absent from all nuclei in 
differentiated multinucleate myotubes (Kemp et al., 2001). In contrast, Palmer et al. 
(2001) found endogenous SMPX immunolocalized primarily to the cytoplasm in both 
C2C12 myoblasts and myotubes.  
In myoblasts, overexpressed FLAG- SMPX was localized to the leading end of 
lamellipodia and focal adhesions. Two myc-SMPX cell lines under the control of 
different promoters and a GFP-SMPX fusion protein, with GFP linked to the N-
terminal side of SMPX, confirmed these results (Palmer et al., 2001). 
In 2005, Schindeler et al. presented additional results on the localization of SMPX in 
C2C12 cell culture, based on the results published by Palmer et al. (2001). When 
studying C2C12 myoblasts, Schindeler et al. (2005) found that MYC epitope-tagged 
SMPX co-localized with actin networks at peripheral membranes and in perinuclear 
compartments; and with the focal adhesion proteins vinculin, paxillin, integrin β1, 
and the small GTPase Rac1. In both C2C12 cells and native muscle, SMPX could be 
co-immunoprecipitated with vinculin. Rac1 is activated and recruited to sites of actin 
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reorganization by growth factors, integrin-mediated cell adhesion to the ECM and by 
biomechanical stress (Clark et al., 1998; Price et al., 1998; Del Pozo et al., 2002; 
Putnam et al., 2003). 
1.2.7 Effects of overexpressing SMPX in cell culture 
Palmer et al. (2001) did overexpression of SMPX in C2C12 muscle cell culture, and 
examined effects on myoblasts and myocyte formation in the presence and absence of 
IGF-1. FLAG-SMPX overexpressing myoblasts in the presence of IGF-1 induced a 
further increase in the activity of the transcription factors NFAT and MEF2 when 
compared to IGF-1 only controls (Palmer et al., 2001). Both NFAT and MEF2 
regulate the myoglobin promoter, which is selectively expressed in slow fibres (Chin 
et al., 1998), and since SMPX itself is enriched in slow fibres, Palmer et al. (2001) 
suggested that SMPX may promote a slow fibre phenotype in C2C12 cells. 
In FLAG- SMPX overexpressing myoblasts, Palmer et al. (2001) also found 
prominent lamellipodia formation accompanied by membrane ruffling and increased 
cell area solely due to cell spreading in the culture dish. Surprisingly, these cells 
migrated more slowly than control cells. Cell division and changes in cell shape and 
behavior, including formation of lamellipodia and membrane ruffling during cell 
migration, are mediated by actomyosin cytoskeletal dynamics and require the Rho 
family of small GTPases (Nobes & Hall, 1995; Kaibuchi et al., 1999; Bishop & Hall, 
2000). The findings of Palmer et al. (2001) suggest that ectopically expressed SMPX 
may engage up- or downstream elements of Rho/Rac-signalling cascades and thus 
dysregulate actomyosin dynamics. It may also function in stabilizing trailing edge 
focal adhesions in C2C12 cells (Palmer et al., 2001).  
Furthermore, when adding IGF-1 to FLAG- SMPX differentiating cells, large 
hypertrophied myotubes termed myosacs (Yotov & St-Arnaud, 1996) appeared. The 
myosac formation was not due to increased anabolic metabolism, but solely due to the 
increased fusion of myoblasts. Palmer et al. (2001) also suggested on basis of their 
findings that myosac formation when overexpressing SMPX may augment and 
dysregulate myosac fusion through perturbation of regulated cytoskeletal dynamics. 
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Schindeler et al. (2005) found that overexpression of the MYC epitope-tagged SMPX 
induced cell spreading (lamellipodia) at the expense of filipodia in a Rac1- and p38 
kinase dependent manner, suggesting that SMPX may participate in regulation of 
cytoskeletal dynamics through the Rac1-p38 pathway (Schindeler et al., 2005). They 
also suggested that SMPX may augment the adhesive function of integrins, since 
MYC- SMPX expression slowed actin turnover at steady state (Huttenlocher et al., 
1995; DeMali et al., 2002; Brakebusch & Fassler, 2003; Nayal et al., 2004).  
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1.3 Aims of the study 
SMPX has been shown to be upregulated in stretched skeletal muscle (Kemp et al., 
2001). SMPX has also been shown to enhance fusion of myoblasts in cell culture, 
leading to large hypertrophied myosacs (Palmer et al., 2001). These results suggest 
SMPX as a candidate for a mechanotransduction pathway leading to hypertrophy. 
SMPX expression was higher in slow-twitch than in fast-twitch fibres (Palmer et al., 
2001), suggesting that SMPX can promote a slow-twitch fibre type. NFAT and MEF2 
activity increased in an IGF-1 dependent manner in SMPX overexpressing C2C12 
cells (Palmer et al., 2001). Since both MEF2 (Potthoff et al., 2007) and NFAT (Chin 
et al., 1998; McCullagh et al., 2004) has been shown to induce a slow fibre type in 
skeletal muscle, this further supports that SMPX may promote a slow fibre-type. 
Previous studies by others have indicated that SMPX can have a function both as a 
structural protein and in the regulation of phenotype in muscle, but the in vivo 
function of SMPX is as yet unknown. 
The aims of my study were to: 
1. Investigate the in vivo localization of SMPX in skeletal muscle in adult mice. 
2. Investigate if overexpression of SMPX in vivo has an effect on fibre type 
distribution and cross sectional area in skeletal muscle in adult mice. 
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2. Materials and methods 
2.1 Animal experiments 
All animal experiments were performed on female NMRI mice (20-40g), held in 
standard cages in the animal facility at the Department of IMBV, UIO, at a 
temperature of 20ºC, and humidity of 50-60%. Food and water were given ad libitum. 
The animal experiments were approved by the Norwegian Animal Research 
Authority, and were conducted in accordance with the Norwegian Animal Welfare 
Act of 20th December 1974 (no. 73, chapter VI, sections 20-22), and the Regulation 
on Animal Experimentation of 15th January 1996. 
2.1.1 Anaesthetization 
Prior to all non-terminal experiments, the mice were anaesthetized with isoflurane 
(Forene, Abbott Laboratories, Abbott Park, IL, USA). The anaesthesia was induced 
by placing the mice in an induction chamber with supply of 2.75% isoflurane. 
Pinching the metatarsus region to ensure that the retraction reflex was absent 
confirmed deep anaesthesia. The mice were then transferred to a mask with airflow of 
600-700 CC/minute, containing between 1.7-2.4% isoflurane. Changes in the 
respiration frequency were used to regulate the anaesthesia dosage. 
For terminal experiments, the mice were anaesthetized with an intraperitoneal 
injection of 5µl/g bodyweight of Equithesin (Ullevål Sykehus, Oslo, Norway). 
Pinching the metatarsus region monitored the depth of anaesthesia, and smaller doses 
were given to sustain deep anaesthesia throughout the experiment. After the 
experiments, the mice were sacrificed by neck dislocation while still under deep 
anaesthesia. 
2.1.2 Animal operation procedures 
For all animal operations, the mice were initially placed on a heated platform that was 
designed to keep the body temperature stable throughout the experiment. The fur was 
removed by shaving and application of hair removal cream (Nair, Carter Products 
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Inc., Folkstone, Kent, England). The hairless area was then washed with 70% ethanol. 
The leg was fastened to a platform, and the muscles were surgically exposed. Pulling 
the overlaying muscles to the sides exposed the EDL and/or soleus muscle. The 
exposed muscles were covered with ringer-acetate solution (Fresenius Kabi Norway 
A/S, N-1753 Halden, Norway). The muscles were then electroporated, made ready 
for imaging, or fixed, as described later. 
2.2 Expression vectors 
It has been demonstrated that when transfecting with two different plasmids, both will 
be transcribed in over 80% of the transfected cells (Utvik et al., 1999). However, 
Rana, et al. concluded that the co-expression can be close to 100% because of 
localized expression and varying degree of sensitivity in the detection (Rana et al., 
2004). 
2.2.1 Fibre type and cross sectional area (CSA) experiments 
To induce overexpression of SMPX in muscle fibres, the plasmid pCMS-EGFP-
SMPX was used (Larsen, 2007) (fig.2.1, C). pCMS-EGFP (Clonetech Laboratories 
Inc., Mountain View, CA, USA) (fig.2.1, B) without Smpx was used as a control. For 
identification of transfected fibres, the muscles were co-transfected with the reporter-
plasmid pAP-lacZ (gift from N. Gautam) (fig.2.1, A). This plasmid has an 
Escherichia coli lacZ-sequence, and expresses the protein β-galactosidase (β-gal), 
which is detected in a colour-reaction where the muscle fibres that express β-gal are 
stained blue. 
2.2.2 Intracellular localization experiments 
In order to study the localization of SMPX in vivo, a fusion-protein was manufactured 
by placing Smpx in at the N-terminal end, in frame with EGFP in the expression-
vector pEGFP-N1 (Clonetech Laboratories Inc., Mountain View, CA, USA) (fig.2.1-
D). This was done because of the putative important area close to the N-terminal end 
of SMPX discussed in the introduction, and the possibility of EGFP affecting this 
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region if flanking the N-terminal end of SMPX. Smpx was isolated from pCMS-
EGFP-Smpx (Larsen, 2007) with the restriction enzymes Nhe1 and Sal1, and the 
multiple cloning site (MCS) of pEGFP-N1 was opened using the same restriction 
enzymes. Smpx was then ligated into the MCS of pEGFP-N1. The new plasmid, 
hereby called pEGFP-N1-Smpx (fig.2.1-E) was modified by removing the kozak 
sequence from the EGFP gene, adding a kozak sequence to Smpx, and removing the 
stop-codon from Smpx using site-directed mutagenesis (QuickChange, Stratagene, 
CA, USA). This was done in order to optimize translation of the fusion protein, 
hereby called SMPX-EGFP. All mutations were verified by sequence analysis, and a 
western blot was performed to verify expression of SMPX-EGFP in HEK-293 cells 
(see results).
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Figure 2.1 Expression vectors 
A) pAP-LacZ (gift from N. Gautam) with the Rous sarcoma virus (RSV) promoter for 
enhanced expression of the LacZ gene in mammalian cells. B) pCMS-EGFP (Clonetech). 
This contains an ampicillin-resistance gene for bacterial selection, a Cytomegalovirus 
(CMV) promoter for enhanced mammalian expression and an EGFP gene for identification 
of transfection in cell culture and in vivo. Following the promoter region is the multiple 
cloning site (MCS) for insertion of genes to be overexpressed. C) pCMS-EGFP-Smpx 
(Larsen, 2007) with Smpx inserted into the MCS of pCMS-EGFP, using the restriction 
enzymes Nhe1 and Xba1  D) pEGFP-N1 used in manufacturing pEGFP-N1-Smpx. It 
contains a CMV promoter, an EGFP gene and a MCS between the two for insertion of Smpx. 
When Smpx is inserted, it will be transcribed in frame with EGFP. It also contains a 
Kanamycin/Neomycin resistance gene for bacterial selection. E) pEGFP-N1-Smpx with 
Smpx inserted into the MCS of pEGFP-N1 in frame with EGFP, using the restriction 
enzymes Nhe1 and Sal1. 
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2.3 Cell culture 
HEK-293 (ATCC: CRL-1573), C2C12 (ATCC: CRL-1772) and NIH/3T3 (ATCC: 
CRL-1658) cells (gift from Jørgen Sikkeland) were used in the experiments. The cells 
were grown in Dulbecco´s modified Eagles medium (DMEM) (GIBCO, Invitrogen, 
Raisley, PA49RF, United Kingdom) containing appropriate amounts of fetal calf 
serum (Bio Whittaker, Lonza, MD, USA) for the respective cell cultures and 100 
U/ml penicillin and streptomycin. All cells were grown in 75cm2 nunclon flasks 
(Nunc A/S, Denmark) in a cell incubator (Farma Scientific Inc, Box 649, Morjetto, 
OHIO, USA) with a set temperature of 37°C, a CO2 level of 5% and humidity of 
100%. All cells were subcultured using 0.1% trypsin EDTA (Bio Whittaker, Lonza, 
Belgium) as previously described (Jainchill et al., 1969), and split approximately 1:10 
every fourth to sixth day, depending on desired cell density. 
Transfections were performed with FuGENE 6 (Roche diagnostics GmbH, 
Mannheim, Germany) according to manufacturers instructions. Cells were plated on 
6-well plastic transfection plates (Nunc A/S, Denmark) for the transfection 
experiments. As a sham control, one well was always transfected with the pCMS-
EGFP plasmid without Smpx inserted. Transfection without any plasmid was used as 
a negative control. All cell culture images shown were obtained 1 day after 
transfection. 
C2C12 cells (Yaffe & Saxel, 1977) were initially used to validate expression of 
SMPX-EGFP prior to animal experiments. The cells were grown in DMEM with 20% 
fetal calf serum to maintain the cells in an undifferentiated myoblast stage, and the 
media was changed to DMEM with 2% fetal calf serum to induce differentiation into 
myotubes. 
HEK-293 cells are a stable embryonic cell line of human kidney cells. They were 
grown in DMEM with 10% calf serum. NIH/3T3 is a fibroblast cell line (Todaro & 
Green, 1963), and they were grown as the HEK-293 cells. 
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2.4 In vivo electroporation 
It has been shown that muscle cells can take up DNA from the interstitium (Wolff et 
al., 1990). Nevertheless, this kind of transfection has an efficiency of about 1%. 
Electrical stimulation can increase the permeability of the cell membrane, and 
transfection efficiency can be increased to over 10% (Mathiesen, 1999). 
Transfection with DNA was performed essentially as described previously 
(Mathiesen, 1999), with some modifications. The muscles were bathed in 10µl DNA 
solution (1µg/µl in 0.9% NaCl) (appendix A) for expression in superficial fibres in the 
localization study. For the fibre typing and cross-sectional area (CSA) studies, a 
syringe (701, Hamilton Company, Reno, Nv, USA) was inserted into the belly of the 
muscle, and 10µl DNA solution (1µg/µl in 0.9% NaCl) (appendix A) was injected with 
a pressure high enough to inflate the muscle and surround the fibres with DNA 
solution. In this way the electroporation efficiency can increase. An electrical field 
was then applied to the muscle using a pulse-generator (Pulsar 6bp-a/s, Fredrick Haer, 
Bowdoinham, ME, USA). Two silver electrodes (1cm long and 2 mm thick) were 
placed on both sides of the muscle, with a distance of approximately 2-3mm between 
them, so that the electrical current was conducted perpendicular to the length of the 
muscle. Five pulse-trains with 1-second intermission were conducted on the muscle, 
and the electrodes were moved length-wise along the muscle between each pulse-
train. Each pulse-train consisted of 1000 symmetrical bipolar square pulses lasting 
200µs in each polarity direction, with total amplitude of 20V. The voltage was 
measured using an analogue oscilloscope (OS245A, Gould Advance, Hainault, Great 
Britain).
 2.5 Fibre type distribution and CSA experiments 
2.5.1 Preparation of muscle serial sections 
14 days after electroporation, muscles were dissected out and pinned onto a rubber 
form. The forms were filled with tissue-tek (Sakura Finetek, Zoeterwoude, Holland) 
and lowered into isopentane cooled to near freezing point (-160°C) in liquid nitrogen. 
This ensured rapid freezing, minimizing freeze-damage. The muscles were stored at -
80°C. The muscles were cryo-sectioned in series of 10 µm sections (HM 560M, 
Microm, Bicester, Oxom, Great Britain). The knife held a temperature of -18°C and 
the preparation -24°C during sectioning. The sections were placed on slides (Super 
Frost Plus, Menzel Gläser, Braunschweig, Germany), air dried and stored at -80°C. 
2.5.2 Staining for β -galactosidase-activity 
The reporter gene lacZ expresses the protein β-galactosidase (β-gal). β-gal is detected 
in a staining-reaction (appendix A) where the substrate x-gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside) is hydrolysed by β-gal, yealding galactose and the 
colourless product indoxyl (5-bromo-4-chloro-3-hydroxyindole). Indoxyl is then 
dimerized/oxidised, forming insoluble blue crystals (5,5-dibromo-4,4-dichloro-
indigo). Fibres that stained for β-gal were counted as transfected fibres. After 
mounting of the stained muscle sections in glycerine gel (appendix A), the staining 
was permanent. The control reaction without x-gal gave no staining (results not 
shown). 
2.5.3 Fibre typing experiments 
The fibre type was determined using monoclonal antibodies against the four muscle-
specific myosin heavy-chains (MyHC) (appendix A, 5.3). The primary antibody (ab) 
binds via the antigen-binding site to a MyHC-epitope that is specific to one or several 
MyHCs. The primary ab is then bound via the FC-region to a secondary ab that is 
conjugated to a fluorescent chromophore. Comparing the different ab stains 
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allowed identification of the different fibre types. Staining without primary ab was 
used as a negative control. No fluorescence was detected in this experiment. 
2.5.4 CSA experiments 
Images from the β-gal sections were used in measuring CSA on muscle fibres. 
Negatively stained fibres were chosen at random from all the transfected muscles and 
used as an internal negative control. Photoshop CS3 extended (Adobe Systems, San 
Jose, CA, USA) were used to encircle the fibres and calculate the pixel value. 
Conversion to µm2 was performed on basis of a micrometer-scale image with the 
same microscope settings. 
CSA in all muscles was normalized by dividing all single fibre values by the average 
of the normal fibres in the same muscle. This was done in order to adjust for possible 
differences in the degree of stretch in the isolated muscles, as there is a linear 
relationship between the degree of stretch and CSA. It also adjusts for the natural 
differences in fibre size between individuals. 
2.6 Fibre type distribution, CSA and cell culture imaging 
2.6.1 Fluorescence microscopy 
Fluorescence images from the fibre type, CSA and cell culture experiments were 
taken with a light sensitive SIT video camera (C2400-08, Hamamatsu Photonics, 
Hamamatsu, Japan) in a dark room. The camera was connected to an upright 
fluorescence microscope (BX 50WI, Olympus, Norwood, MA, USA) with a 10x, 20x 
40x or 60x water immersion objective (UMPlan, FI, Olympus, Tokyo, Japan). An 
adjustable 12 V, 100 W halogen lamp was used for epi-illumination, and precautions 
were taken to minimize the time and intensity of light exposure in order to avoid 
phototoxicity. The filter cube XF33, XF22 and XF11 (Omega Optical Inc., 
Brattleboro, VM, USA) was used to illuminate the samples with the correct 
wavelength. The pictures were digitalized using an Argus 20 picture processor 
(Hamamatsu photonics, Hamamatsu, Japan), transferred to a Power Macintosh G3 
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and further processed in Photoshop CS3 extended (Adobe Systems, San Jose, CA, 
USA). 
2.6.2 Light microscopy 
Sections stained for β-gal activity were photographed with a CCD videocamera 
(C2400, Hamamatsu Photonics, Hamamatsu, Japan) connected to a microscope (BX 
50WI, Olympus, Tokyo, Japan) with a 10x water immersion objective (UMPlan, FI, 
Olympus, Tokyo, Japan). Images were digitalized and processed in the same way as 
the fluorescence images. 
2.7 Intracellular localization experiments 
2.7.1 Preparation of fixed muscles for confocal imaging 
For the imaging experiments, 1-2 days after electroporation of superficial fibres in 
EDL and soleus, the muscles were fixed in 4% paraformaldehyde diluted in relaxing 
solution (FIX) (137mM NaCl, 5.4mM KCl, 5mM MgCl2, 4mM EGTA, 5mM 
HEPES, pH7.0) (Wada et al., 2002) by heart perfusion (Slezak & Geller, 1979). After 
anaesthetizing the mice, the feet were pinned up and stretched on a polystyrene plate. 
The thorax was opened, and the heart located. The right atrium was cut open, and 
from the apex of the left ventricle the heart was perforated with a 20ml syringe 
(Beckton Dickinson, Drogheda, Ireland). 20ml FIX was then injected with high 
pressure to replace all the blood and interstitial fluids with FIX, thereby fixating the 
muscles. The whole procedure was performed in a timeframe maximum of 5 minutes 
to ensure that the muscle protein was not degraded. EDL and soleus were isolated and 
directly bathed in FIX for another 10 minutes to ensure thorough fixation of the 
superficial fibres. The muscles were washed three times in PBS (pH=7.4) (appendix 
A) and stored in PBS in the dark at 4°C. 
2.7.2 Immunohistochemistry on single fibres 
Fibres positive for EGFP were located using a fluorescence microscope (BX 50WI, 
Olympus, Tokyo, Japan), and mechanically isolated from the fixed muscles using 
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tweezers and pins under a binocular microscope. The isolated fibres were transferred 
to a glass slide (Super Frost Plus, Menzel Gläser, Braunschweig, Germany) and air-
dried for 10 minutes to allow attachment to the slide. The fibres were permeabilized 
with 0.5% Triton X-100 (Sigma Chemical) in PBS (pH=7.4) for 10 minutes, then 
blocked with 3% BSA (Sigma Chemical), 0.1% Triton X-100 in PBS for 15 min. 
Primary antibodies (appendix A) were diluted in PBS with 1% BSA and applied to 
the slides for 60 min at room temperature. Following three washing steps with PBS 
containing 0.1% Triton X-100, the slides were incubated at room temperature for 45 
min with secondary ab (appendix A) diluted in PBS containing 1% BSA. After 
washing the fibres twice with 0.1% Triton X-100 in PBS and once with PBS, the 
fibres were mounted with ProLong Gold with DAPI (Invitrogen, Oregon, USA). 
Non-fluorescent fibres were used as negative controls. (Modified protocol from 
(Averbeck et al., 2007). 
2.7.3 Confocal microscopy and imaging 
Imaging with a confocal microscope (Olympus BX61WI, Tokyo, Japan) connected to 
an imaging system (Olympus fluoview FV1000, Olympus, Europe GmBH) was 
performed on all the fibres from the in vivo experiments and on the isolated fibres 
from the SMPX-EGFP fusion protein experiments. An argon ion laser (Melles Griot, 
Stockholm, Sweden) was used as the light source. The fibres were scanned 
sequentially with the different wavelengths to hinder false imaging by the partly 
overlapping emitted light, and each sample were scanned ≥ 3 consecutive times 
(Kalman mode) to remove background noise from the sample. All adjustments were 
performed through the software-program FV10-ASW version 1.7 (Olympus), which 
was connected to the microscope. All images were taken with a 100X oil objective 
(UPlanApo) with numerical aperture (n.a.) 1.35. The images were further processed 
in FV10-ASW version 1.7 and Photoshop CS3 extended (Adobe Systems, San Jose, 
CA, USA). 
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2.8 Statistical analyses 
All statistical calculations were done in Prism4 (Graph Pad Software Inc., San Diego, 
CA, USA), with a level of significance set to 5%. The fibre type distribution in 
normal control, sham control and SMPX muscle fibres were compared using a chi-
square test. The CSA were compared using a Oneway ANOVA with a Bonferroni 
post test. ANOVA is a parametric test that assumes a normalized distribution. In all 
graphs presented in the results the P values are expressed with the following symbols: 
P<0.001= ***, 0.001≤P≤0.01= **, 0.01<P≤0.05 = *, P>0.05= n.s. (non significant). 
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3. Results 
3.1 Intracellular localization of SMPX 
3.1.1 Verification of protein expression 
A western blot analysis was performed on cell lysates from HEK-293 cells to verify 
SMPX-EGFP fusion protein expression. The blot confirmed expression of SMPX-
EGFP from 4 independent pEGFP-N1-Smpx transfected cultures, with a band at 
approximately 40kDa (fig.3.1, lane 3-6). In the control, transfected with pCMS-
EGFP-Smpx, a band at approximately 27kDa confirmed EGFP expression. The 
negative control without transfection did not show any specific bands at the size of 
either SMPX-EGFP or EGFP. A weak EGFP band could also be seen in lane 3-6, 
where only SMPX-EGFP should be expressed. This shows that transcription and 
translation of EGFP alone also takes place. Still, the signal is much stronger for the 
SMPX-EGFP band, confirming better transcription and/or translation of SMPX-
EGFP. The weak EGFP band is considered not to affect the localization results. 
HEK-293 cells transfected with pCMS-EGFP-Smpx has previously verified SMPX 
overexpression with northern blotting (Larsen, 2007). 
 
Figure 3.1 Western blot of SMPX-EGFP expression in HEK-293 cells 
Stained with an ab against EGFP. Lane nr: 1) Negative control. 2) EGFP only. 3-6) SMPX-
EGFP. 
3.1.2 SMPX-EGFP distribution in cell culture 
Cells transfected with pEGFP-N1-Smpx had a distinct localization of the SMPX-
EGFP fusion protein, depending on the cell culture, and it was invariably excluded 
from the nuclei (fig. 3.2, left hand column). SMPX-EGFP was localized to the 
membrane in the HEK-293 cells (fig. 3.2, A).  SMPX-EGFP showed a patchy 
distribution in the cytoplasm of both the NIH/3T3 fibroblasts (fig.3.2, C) and in the 
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C2C12 myoblasts (fig.3.2, E). SMPX-EGFP was denser towards the periphery in the 
myoblasts, while it was denser in the perinuclear areas in the fibroblasts. Cells 
transfected with pCMS-EGFP-Smpx, expressing EGFP and SMPX separately, had a 
uniform distribution of EGFP throughout the cell (fig. 3.2, right hand column). 
Myotubes had a patchy distribution of SMPX-EGFP in the cytoplasm, as seen in the 
myoblasts and fibroblasts. Due to a degradation process in the cells expressing 
SMPX-EGFP and difficulties in transfecting myotubes, no good images on the 
localization of SMPX-EGFP were obtained from myotubes at early stages after 
transfection (see discussion).
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Figure  3.2 SMPX-EGFP intracellular localization in cell culture 
A-B) HEK-293 cells. C-D) NIH/3T3 fibroblast cells. E-F) C2C12 myoblast cells. Green 
fluorescence represents the SMPX-EGFP fusion protein in the left column and EGFP in the 
right column. Blue fluorescence represents nuclei, stained with Hoechst-33342. Images were 
taken with a SIT camera on an upright fluorescence microscope. Scale bars: 10µm.
 3.1.3 In vivo localization of SMPX-EGFP 
Live, anaesthetized mice were placed under an upright confocal microscope in order 
to look at the in vivo intracellular localization of the SMPX-EGFP fusion protein in 
single fibres. A clear localization of SMPX-EGFP could be seen in repetitive cross 
striations (fig. 3.3, A). The control fibres, expressing EGFP and SMPX separately, 
had a uniform distribution throughout the cytoplasm (fig. 3.3, B). 
  
Figure 3.3 SMPX-EGFP localization in live fibres in anaesthetized mice 
A) Fibre electroporated with pEGFP-N1-Smpx, expressing SMPX-EGFP fusion protein in 
green. B) Fibre electroporated with pCMS-EGFP-Smpx, expressing EGFP (green) and 
SMPX separately (control). Images were taken with an upright confocal microscope. Scale 
bars: 10µm. 
3.1.4 SMPX-EGFP localization in isolated fibres 
To further deduce the SMPX-EGFP localization in relation to other structural 
elements in the muscle fibre, fixation and mechanical separation of single fibres was 
performed. A toxin binding filamentous actin (phalloidin) was used (fig.3.4). The 
phalloidin first binds at both ends of the actin filaments and at the Z-disc, and the 
areas in between are stained in a time dependent manner (Balnave et al., 1997). Due 
to the harsh treatment of the fibres, including mechanical separation, permeabilization 
and repeated staining and washing procedures, the SMPX-EGFP signal became 
weaker. The EGFP ab was therefore used to reinforce the initial SMPX-EGFP 
fluorescence signal (fig. 3.4). 
SMPX-EGFP was localized to the H-zone at the level of the myosin filaments, with 
little or no overlap with actin filaments (fig.3.4, A-C). A very weak band of SMPX-
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EGFP could also be seen at the level of the Z-disc (fig. 3.4, B, dark blue arrow). This 
band is not visible on the overlay (fig. 3.4, C) image because of the much stronger 
signal from the phalloidin staining.  The normal control fibres (fig. 3.4, D-F) had no 
intracellular staining with the EGFP ab, but some staining at the membrane was 
evident. I attribute this to non-specific binding or autofluorescence due to one or 
more of the steps in the treatment of the isolated fibres.
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Figure 3.4 SMPX-EGFP localization in single isolated fibres 
Triple immunofluorescence confocal images of mechanically isolated and fixed skeletal 
muscle fibres, showing GFP ab in green, actin stained with phalloidin in red and nuclei 
stained with Hoechst-33342 in blue. A-C) SMPX-EGFP expressing fibre. D-F) A normal 
control fibre. The bottom row is an overlay of the top two rows, in addition to a Hoechst-
33342 image. Scale bars: 5µm. 
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In order to verify the localization observed with the phalloidin staining, double 
staining with antibodies against MyHC and phalloidin toxin was performed on 
normal fibres (fig. 3.5). The images indicate a localization of SMPX-EGFP to the H-
zone. This part of the myosin filaments does not participate in the actin-myosin 
crossbridge cycling, but it holds many other structural and signalling proteins, many 
with an unknown function, and still more progressively being discovered (Kruger and 
Linke 2009). The SMPX-EGFP band was much narrower than the MyHC band 
(compare 3.4, B and 3.5, A), supporting a localization of SMPX-EGFP to the middle 
part of the myosin filament. The MyHC band was overlapping quite extensively with 
the ends of the actin band (yellow in fig. 3.5, C).  SMPX-EGFP was not overlapping 
with the ends of the actin band (fig. 3.4, B-C), except from the very weak band of 
SMPX-EGFP at the Z-disc (fig. 3.4, B). 
      
Figure 3.5 Actin filaments and MyHC staining in a normal fibre 
Triple immunofluorescence confocal images of a mechanically isolated and fixed skeletal 
muscle fibre, showing myosin stained with a MyHC ab (my-32) in green, actin stained with 
phalloidin toxin in red and nuclei stained with Hoechst-33342 in blue. A) A green arrow 
indicates the middle of an A-band, and green indicates the myosin filaments. B) A red arrow 
indicates a Z-disc, and red indicates the actin filaments. C) The overlay of A and B shows 
that the myosin and actin filaments are partly overlapping (yellow). Blue represents Hoechst-
33342, marking nuclei. Scale bars: 2.5µm.
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3.2 Effects of SMPX on fibre type distribution 
3.2.1 Fibre type distribution EDL 
The fibre type distribution was not significantly different between the sham and 
SMPX transfected groups (p>0.05) (fig. 3.6 and table 3.1). There was a general shift 
towards a faster fibre type in the sham and SMPX transfected groups when compared 
with the normal group. An increase in type 2b fibres at the expense of type 2a and 2x 
fibres was evident. The fibre type distribution in both the sham and SMPX 
transfected groups were significantly different from the normal control group 
(p<0.0001). There was a 37% increase in type 2b fibres in the sham group compared 
with the normal group. There was a 26% increase in type 2b fibres in the SMPX 
group compared with the normal group.  
 
Figure 3.6 Fibre type distribution EDL 
*** = p<0.001, n.s. = non significant. For further information, see table 3.1. 
Table 3.1 Fibre type distribution EDL 
 Normal Sham SMPX 
Fibre type 2a (%) 18.7 2.9 7.6 
Fibre type 2x (%) 22.0 15.7 17.5 
Fibre type 2b (%) 59.3 81.4 74.9 
    Number of fibres 2787 172 251 
Number of muscles 4 3 5 
 
 31 
3.2.2 Fibre type distribution soleus 
The fibre type distribution was significantly different between the sham and SMPX 
transfected groups (p=0.0474). There was a 23% decrease in type 1 fibres in the 
SMPX group when compared with the sham group (fig. 3.7 and table 3.2). A shift 
towards a faster fibre type in the sham and SMPX transfected groups was seen when 
compared with the normal group. There was also a shift towards a faster fibre type in 
the SMPX group when compared with the sham group. An increase in type 1/2a and 
2a fibres at the expense of type 1 fibres was evident. The fibre type distribution in the 
sham group was significantly different from the normal control group (p=0.0053). 
There was a 14% decrease in type 1 fibres in the sham group when compared with the 
normal group.  The fibre type distribution in the SMPX group was significantly 
different from the normal control group (p<0.0001). There was a 33% decrease in 
type 1 fibres in the SMPX group when compared with the normal group. 
 
Figure 3.7 Fibre type distribution soleus 
*** = p<0.001 ** = p<0.01 * = p<0.05. For further information, see table 3.2. 
Table 3.2 Fibre type distribution Soleus 
 Normal Sham SMPX 
Fibre type 1 (%) 58.7 50.6 39.1 
Fibre type 1/2a (%) 6.7 9.8 13.9 
Fibre type 2a (%) 34.6 39.6 47.0 
    Number of fibres 1959 399 153 
Number of muscles 3 6 6 
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3.3 Effects of SMPX on CSA 
3.3.1 CSA EDL 
There was no significant change in CSA in the SMPX group when compared with the 
sham group (p>0.05). There was a small, but still significant increase in CSA by 5% 
in the SMPX group when compared with the normal group (p<0.05). There was also 
a small, but still significant increase in CSA by 7% in the sham group when 
compared with the normal group (p<0.01). 
 
Figure 3.8 CSA distribution EDL 
Each dot represents one fibre CSA value. Mean with standard deviations are shown. ** = 
p<0.01, * = p<0.05, n.s. = non significant. For further information, see table 3.3. 
Table 3.3 CSA distribution EDL 
 Normal Sham SMPX 
Mean 1.000 1.065 1.052 
Std. deviation 0.221 0.248 0.229 
SEM 0.011 0.019 0.015 
    Number of fibres 423 164 232 
Number of muscles 4 3 5 
Normality test p>0.10 p>0.10 p>0.10 
 3.3.2 CSA soleus 
There was a significant increase in fibre CSA of 11% in the SMPX group when 
compared with the sham group (p<0.01). There was no significant change in the 
SMPX group when compared with the normal group (p>0.05). Fibre CSA was 
decreased by 12% in the sham group when compared with the normal group 
(p<0.001). 
 
Figure 3.9 CSA distribution soleus 
Each dot represents one fibre CSA value. Mean with standard deviations are shown. *** = 
p<0.001, ** =p<0.01 n.s. = non significant. For further information, see table 3.4. 
Table 3.4 CSA distribution soleus 
 Normal Sham SMPX 
Mean 1.000 0.877 0.971 
Std. deviation 0.251 0.294 0.275 
SEM 0.010 0.016 0.024 
    Number of fibres 583 347 128 
Number of muscles 3 6 6 
Normality test p = 0.0009 p>0.10 p>0.10 
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4. Discussion 
4.1 Subcellular localization of SMPX 
Our results show that SMPX-EGFP was absent from all nuclei both in vivo and in cell 
culture, indicating that SMPX did not work as a transcription factor under our 
experimental conditions. Our results are consistent with the cell culture 
immunolocalization results of endogenous SMPX from Palmer et al. (2001), but in 
disagreement with Kemp et al. (2001), who found SMPX immunolocalized to both 
nuclei and cytoplasm. 
SMPX-EGFP had a patchy localization in the cytoplasm of the myoblasts, myotubes 
and fibroblasts in our experiments. This is in contrast to Palmer et al. (2001), who 
localized a GFP-SMPX fusion protein to the leading end of lamellipodia and focal 
adhesions. Localization of SMPX-EGFP to the membrane in the HEK-293 cells is 
difficult to interpret. Cells that do not express endogenous SMPX could misinterpret 
a localization signal.  
Cell cultures with SMPX-EGFP lacked both costameres and a contractile apparatus, 
and the morphology and physiology of these cells were different from that of muscle 
fibres in vivo. An interpretation of our cell culture localization other than excluding 
SMPX-EGFP from the nuclei is therefore troublesome. 
Our in vivo results indicate that the major portion of SMPX is localized to the H-
zone, where myosin filaments do not overlap with actin filaments (fig. 4.1). With a 
localization to the H-zone, SMPX would join a series of proteins that have been 
localized to this part of the sarcomere; such as muscle specific RING fingers 
(MURFs) and the zink finger proteins neighbor-of-BRCA1-gene-1 (Nbr1) and p62 
((Hoshijima, 2006; Kruger & Linke, 2009). Our results are in contrast to Palmer et al. 
(2001), who implied that the major portion of SMPX is localized to the I-band, 
flaking the Z-disc. However, Palmer et al. (2001) also found SMPX immunolocalized 
to the level of the M-line, with a stronger signal in heart muscle than in skeletal 
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muscle. They do not speculate whether this can be at the level of the contractile 
apparatus or not. 
Our experiments show that a minor portion of SMPX may be localized to the Z-disc 
(fig. 4.1). The Z-disc SMPX-EGFP signal was only detected with a GFP antibody in 
isolated fibres, but not in the in vivo experiments. This could be an issue of 
sensitivity, considering that SMPX-EGFP had a weaker fluorescence signal than the 
EGFP antibody. SMPX localization to the Z-disc has not been reported in previous 
studies. 
 
Figure 4.1 Schematic drawing of a skeletal muscle sarcomere with postulated 
SMPX localization 
Modified from fig. 1.1 in the introduction; with localization of SMPX-EGFP (green) to the 
H-zone and the middle of the Z-discs added to the drawing. 
In localization studies, a GFP fusion protein can be superior to antibodies because it 
is possible to study the in vivo distribution. In addition, non-specific binding of an 
antibody is not an issue. Indeed, Palmer et al. (2001) pointed out that the SMPX 
antibody cross-reacted with desmin, and that the pattern of SMPX in transverse 
sections of fetal myotubes resembled that of desmin. They try avoiding the problem 
by pre-immunoabsorption of the SMPX antibody against desmin. Kemp et al. (2001) 
also reported non-specific binding of their SMPX antibody. On the other hand, there 
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could also be problems linked to the use of a fusion protein. A protein tag could alter 
the endogenous localization e.g. by covering the localization signal. 
Palmer et al. (2001) indicated costameric localization of SMPX in adult skeletal 
muscle. Yet, the only images showing SMPX surrounding myofibrils were of 17.5 
day old embryos. Data from adult tissue was not shown. Further in vivo imaging 
studies with better sensitivity and resolution could confirm our Z-disc localization 
and rule out the possibility of non-specific GFP antibody staining and other ex vivo 
artefacts. Whether SMPX is found throughout the myofibril or surrounding it, and 
which proteins it interacts with, can be investigated with a three dimensional 
reconstruction of high-resolution confocal images or with electron microscopy. 
4.2 Degradation of cells expressing SMPX-EGFP 
In both cell culture and in vivo experiments, a degradation process leading to cell 
death started at day 1-3 after pEGFP-N1-Smpx transfection, with cells expressing 
more SMPX-EGFP degrading at an earlier time point. All images from our 
localization study were therefore obtained at an early time point, when the cells and 
fibres displayed normal morphology. The in vivo images showed a more patchy 
localization of SMPX-EGFP late in the degradation process, resembling the cell 
culture patchy localization. 
One can attribute the cell death to cytotoxicity, which has been reported previously 
with overexpression experiments e.g. with a GFP fusion protein (Triplett & Pavalko, 
2006; Wang et al., 2006; Wang & Monteiro, 2007). Overexpression can lead to 
cytotoxicity e.g. by forming protein aggregates. Poly-glutamine and poly-alanine are 
examples of domains that can lead to aggregation of an overexpressed fusion protein 
(Wang et al., 2006; Wang & Monteiro, 2007). A GFP fusion protein can then be seen 
with a patchy distribution in the cytoplasm (Wang, Lim et al. 2006). The FuGENE 6 
protocol (Roche diagnostics GmbH, Mannheim, Germany) also reports that high 
expression levels of certain intracellular proteins (e.g. GFP) may be cytotoxic to some 
cell types. 
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Preliminary results from cell culture (results not shown) indicated that HEK-293 cells 
overexpressing SMPX-EGFP had a better survival rate than fibroblasts, myoblasts 
and in vivo muscle fibres. This can be attributed to the HEK-293 cells being more 
resistant to cytotoxicity. In my experiments, the fibroblasts and myoblasts had a 
shorter generation time than the HEK-293 cells (results not shown). A shorter 
generation time demands a higher metabolism, and thereby also a higher protein 
turnover. The higher protein turnover may lead to SMPX-EGFP reaching cytotoxic 
levels at an earlier time point. 
Another explanation for the cell death can be that SMPX-EGFP works as a dominant 
negative, quenching the function of the endogenous SMPX (Ilkovski et al., 2004; 
Wang et al., 2006; Zhang et al., 2006). The superior survival rate in the HEK-293 
cells can then be explained by SMPX having a less critical function in these cells.  
Whether SMPX-EGFP is cytotoxic or working as a dominant negative can be 
investigated with a study of competition between overexpressed endogenous SMPX 
and SMPX-EGFP, monitoring the cell death occurrence with an apoptosis kit. 
4.3 Effects of SMPX on fibre type distribution and CSA 
Our experiments showed that overexpression of SMPX for 14 days did not 
significantly alter the fibre type distribution or CSA in EDL. On the other hand, the 
soleus experiments had a shift towards a faster fibre type, with a mean decrease of 
23% in type 1 fibres in the SMPX group compared with the sham group. However, 
the differences between the sham and SMPX group were only borderline significant: 
p=0.05. CSA was also significantly different between the sham and SMPX group in 
soleus, with a minor increase of 11% in the SMPX group compared with the sham 
group. 
When comparing the sham and SMPX group in the same individual, the changes 
were not consistent. Some of the individuals even showed a change towards a slower 
fibre type and decreased CSA. There were also individual differences, and the 
number of fibres transfected in each muscle were highly variable. The overall 
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changes seen in the soleus could therefore be a result of chance. Experiments with a 
larger number of animals are needed to see if the effects seen in soleus are 
reproducible.     
4.3.1 Selective transfection in electroporated mice muscle 
The use of a sham control group is important to exclude possible effects following the 
electroporation procedure and uptake of foreign DNA. In both EDL and soleus, both 
the sham and SMPX transfected fibres displayed a faster fibre type distribution than 
the normal fibres from the same muscles. We attribute this to a selective transfection 
of fibres. The reason for this is at the present time not known. This selectivity has 
been confirmed by several others in our research group, and has been observed in 
mice, but not in rats (results not shown). The difference in size between rat and mice 
seen both at the macroscopic and cellular level may lead to important differences in 
geometry and strength of the electrical field during electroporation. We therefore find 
the comparison between the sham and SMPX groups to be the most reliable. 
4.4 Possible functions of SMPX in skeletal muscle 
In earlier studies of SMPX (Patzak et al., 1999; Kemp et al., 2001; Palmer et al., 
2001) it has been suggested that it could function both as a structural protein and a 
gene regulatory protein. Our effects of SMPX on fibre type distribution and CSA 
were relatively small, and one can question if they are genuine. Much of the 
experiments on SMPX have had a main focus on cell culture experiments. Our work 
has had a main focus on in vivo experiments, and it showed that SMPX generally 
does not promote a slow fibre type. Our results rather suggest a small shift in the fast 
direction. In contrast, Palmer et al. (2001) found increased MEF2 and NFAT activity 
in cell culture when overexpressing SMPX, and they speculated that SMPX may 
promote a slow fibre type. 
Our results suggest that SMPX does not induce hypertrophy in EDL in adult skeletal 
muscle. Further studies are needed to confirm the changes seen in soleus, and a 
possible effect does not necessarily contradict SMPX being a structural protein. In 
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contrast, Kemp et al. (2001) found SMPX upregulated in the tibialis anterior muscle 
in response to 7 days of passive stretch. Kemp et al. (2001) therefore suggested that 
SMPX may induce hypertrophy in adult skeletal muscle. 
That SMPX-EGFP is excluded from the nuclei at all times in our experiments 
supports a theory that SMPX is not working as a gene regulatory protein. 
Localization to the H-zone can then suggest a function as a structural protein with a 
possible link to a mechanical function in stretch and/or contraction. A structural 
protein could still indirectly affect the phenotype by being present in this force 
generating area; e.g. by changing the flexibility of the muscle, or by indirectly 
influencing a stretch-response or the contraction coupling. This is supported by there 
being highest levels of SMPX in soleus, and it can possibly have a more important 
structural role there than in EDL. This could explain the changes in fibre type 
distribution and CSA seen in soleus but not in EDL. 
We have found that SMPX probably does not co-localize with actin filaments in vivo. 
In contrast, Schindeler et al. (2005) found that MYC epitope-tagged SMPX co-
localized with actin networks at peripheral membranes and in perinuclear 
compartments in vitro. 
The localization to the H-zone of the sarcomere, with a uniform signal throughout the 
H-zone, makes it intriguing to suggest that SMPX is bound to the central parts of the 
MyHC or the central parts of titin. It could also be a structural protein linking the two 
together. This is a plausible explanation, since both MyHC and titin are abundant and 
evenly distributed at the level of the H-zone throughout the sarcomere. This is in 
aggrement with our postulated even distribution of SMPX in this area. The titin 
COOH-terminal segment within and adjacent to the M-band has been shown to take 
part in several protein-protein interactions (Kruger and Linke 2009). This further 
supports the idea that SMPX could be linked to titin. 
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4.5 Future experiments 
Taken that our results on fibre type distribution and CSA in soleus are somewhat 
unclear, new experiments with a larger number of animals should be performed to see 
if the results are reproducible. 
A three dimensional reconstruction of in vivo confocal images with SMPX-EGFP can 
be performed to further deduce its localization. Electron microscopy could in this 
context also be applied in order to obtain high-resolution images. Whether SMPX-
EGFP localizes to the H-zone inside myofibrils, at costameres or both can be 
investigated with these methods. There is also a possibility that SMPX is localized 
both inside and surrounding myofibrils.
 4.6 Conclusions 
• SMPX-EGFP was excluded from nuclei under our experimental conditions. 
• SMPX-EGFP localized to the H-zone, with a minor portion possibly localized 
to the middle of the Z-disc in adult skeletal muscle. 
• SMPX overexpression had no effect on fibre type distribution or CSA in EDL. 
• SMPX overexpression could have changed the fibre type distribution in the 
fast direction and increased fibre CSA in soleus. 
Our experiments do not support the idea that SMPX is a gene regulatory protein or a 
major signalling molecule related to force transduction in the I-band. 
It remains unclear if SMPX has an effect on muscle phenotype, directly or indirectly. 
Our results suggest that SMPX works mainly as a structural protein, with a possible 
connection with mechanical proteins like titin and myosin in the sarcomere in skeletal 
muscle. 
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5. Appendix A 
5.1 DNA electroporation solution (1µg/µl) 
4M NaCl 4µl 
dH2O 46µl 
Reporter DNA (pAP-lacZ, 2µg/µl) (gift from N. Gautam) 25µl 
Fibre type and CSA experimental DNA (pCMS-EGFP-Smpx) or control DNA          
(pCMS-EGFP) (2µg/µl) 
25µl 
Localization experimental DNA (pEGFP-N1-Smpx) or control DNA (pEGFP-N1) 
(2µg/µl) 
25µl 
TOTAL 100µl 
 
5.2 β-galactosidase staining 
Fix solution: 
Formaldehyde 2g 
Glutaraldehyde 400µl 
10xPBS 10ml 
dH2O 90ml 
 
1. Dissolve formaldehyde in 70ml dH2O heated to 60°C.  
2. Add in PBS. 
3. Cool off and add glutaraldehyde. 
4. Adjust the pH to 7.1 with phenol red. 
Staining solution: 
10xPBS 150µl 
0.2M potassium-ferrocyanide 30µl 
0.2M potassium-ferricyanide 30µl 
1M MgCl2 3µl 
dH2O 1260µl 
X-gal (50g in DMSO, Promega) 30µl 
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1. Draw a ring around the sections with a hydrophobic marker (H-4000, Vector 
Laboratories, Burlingame, CA, USA). 
2. Fix with fixation solution at 4°C for 20 minutes. 
3.  Rinse 3x in PBS (pH 7.4). 
4. Stain over night at 37°C. 
5. Rinse 3x in PBS (pH 7.4). 
6. Mount in glycerine gel: 
Glycerine 15.0g 
Glycerol 100ml 
dH2O 100ml 
 
5.3 Antibody staining of MyHC 
MyHC Primary 
ab 
Secondary ab 
Type I BA-D5 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, F-9137) 
All type 
II 
My-32 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, F-9137) 
Type IIa Sc-71 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, F-9137) 
All non 
IIx 
BF-D5 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, F-9137) 
Type IIb BF-F3 Anti-mouse IgM (Cy3.conjugated, J 115-165-020, Jackson 
ImmunoResearch Laboratories, West Grove, PE, USA) 
The antibodies BA-D5, Sc-71 and BF-F3 were a gift from Stefano Schiaffino. My-32 
(Molecular probes, Invitrogen Corp., Carlsbad, CA, USA). 
Antibody staining of MyHC type I, type IIa, all type II and all non IIx: 
1. Draw a ring around the sections with a hydrophobic marker (H-4000, Vector 
Laboratories, Burlingame, CA, USA). 
2. Dilute primary ab 1:1000 in 1% BSA in PBS (pH 7.4). 
3. Incubate the sections with primary ab for 60 minutes at room temperature.  
4. Wash 3x 5 minutes in PBS (pH 7.4).  
5. Dilute secondary ab 1:200 in 0.5% BSA in PBS (pH 7.4). 
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6. Incubate the sections with secondary ab for 30 minutes at 37°C. 
7. Wash 3x 5 minutes in PBS (pH 7.4). 
Ab staining of MyHC IIb: 
1. Draw a ring around the sections with a hydrophobic marker (H-4000, Vector 
Laboratories, Burlingame, CA, USA). 
2. Preincubate with 1% BSA in PBS (pH 7.4) for 60 minutes at 4°C. 
3. Dilute primary ab 1:1000 in 0.5% BSA in PBS (pH 7.4). 
4. Incubate the sections with primary ab for 45 minutes at 37°C. 
5. Rinse 3x 5 minutes in PBS (pH 7.4).  
6. Dilute secondary ab 1:200 in 0.5% BSA in PBS (pH 7.4).  
7. Incubate the sections with secondary ab for 45 minutes at 37°C.  
8. Wash 3x 5 minutes in PBS (pH 7.4). 
5.4 Immunohistochemistry on single fibres 
Binds with: Primary ab: Dilution: Secondary ab: 
MyHC My-32 1:2000 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, 
F-9137) 
Filamentous 
actin 
Phalloidin-
TRITC (toxin) 
1:2000 Directly linked to TRITC (Sigma Life Science, 
1951) 
EGFP Mouse anti-
GFP 
1:2000 Rabbit anti-mouse IgG (FITC-conjugated, Sigma, 
F-9137) 
 
5.5 10x PBS solution pH 6.9→1x pH 7.4 
NaCl 80g 
KCl 2g 
Na2HPO4 x 2H2O 14.4g 
KH2PO4 2g 
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6. Appendix B- Abbreviations 
Aa = amino acid 
Ab = antibody 
bHLH = basic helix-loop-helix 
β-gal = β-galactosidase 
BSA = bovine serum albumin 
CMV = cytomegalovirus 
CSA = cross-sectional area 
CsCl = cesium chloride 
DAPI = 4,6-diamidino-2-phenylindole 
DMEM = Dulbeccos modified Eagles medium 
DMSO = Dimethyl sulfoxide 
ECM = extracellular matrix 
EDTA = ethylenediaminetetraacetic acid 
EGFP = enhanced green fluorescent protein 
EGTA = ethylene glycol tetraacetic acid 
EDL = extensor digitorum longus 
IGF-1 = insulin-like growth factor-1 
kDa = kilodalton 
MCS = multiple cloning site 
MEF2 = myocyte-specific enhancer factor 2 
MGF = mechanogrowth factor 
MRF = myogenic regulatory factor 
MURF = muscle-specific RING finger 
MyHC = myosin heavy chain 
MyLC = myosin light chain 
neighbor-of-BRCA1-gene-1 = Nbr1 
NFAT = nuclear factor of activated T-cells 
PBS = phosphate buffered saline 
RSV = rous sarcoma virus 
Smpx = small muscle protein X-chromosome (gene) 
SMPX = small muscle protein X-chromosome (protein) 
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